AMYLYX PHARMACEUTICALS INC's ticker is and the CUSIP is 03237H101. A total of 175 filers reported holding AMYLYX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,920,910 | -59.4% | 760,290 | -52.2% | 0.02% | -57.1% |
Q2 2023 | $34,297,249 | -42.2% | 1,590,044 | -21.4% | 0.04% | -45.3% |
Q1 2023 | $59,336,336 | +16.1% | 2,022,370 | +46.2% | 0.06% | +12.3% |
Q4 2022 | $51,128,897 | +1019.3% | 1,383,732 | +752.8% | 0.06% | +1040.0% |
Q3 2022 | $4,568,000 | – | 162,265 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpha Wave Global, LP | 930,337 | $27,296,088 | 10.08% |
Perceptive Advisors | 6,034,644 | $177,056,455 | 5.23% |
GREAT POINT PARTNERS LLC | 783,795 | $22,996,545 | 4.52% |
Ghost Tree Capital, LLC | 475,000 | $13,937,000 | 4.12% |
Altium Capital Management LP | 185,000 | $5,427,900 | 3.01% |
Boxer Capital, LLC | 2,084,000 | $61,145 | 3.00% |
EMERALD MUTUAL FUND ADVISERS TRUST | 789,591 | $23,166,600 | 1.37% |
EMERALD ADVISERS, LLC | 972,835 | $28,542,979 | 1.37% |
SECTORAL ASSET MANAGEMENT INC | 242,400 | $7,112,016 | 1.37% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,984,333 | $58,220,330 | 1.30% |